Vacation for Cause: 2016 Buckeye Cruise for Cancer Sets Sail in February

September 28, 2015
Buckeye Cruise for Cancer

COLUMBUS -- Ohio State fans have the chance to vacation with OSU Head Football Coach Urban Meyer and dozens of their favorite former Buckeye athletes by participating in the 2016 Buckeye Cruise for Cancer, a five-day cruise that supports cancer research at The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC – James).  

More than 30 OSU athletic icons are expected to participate in the 2016 event, including current Ohio State football coach Urban Meyer as well as Evan Spencer, Joey Galloway, Archie Griffin, AJ Hawk, Craig Krenzel, Robert Smith and several other former Buckeyes currently playing in the NFL.

Cabins are still available for purchase for the ninth annual cruise, which sets sail from Fort Lauderdale, Florida, Saturday, Feb. 20, 2016, and travels to Royal Caribbean’s private island, Labadee, and Ocho Rios, Jamaica. Proceeds from the cruise benefit the Urban and Shelley Meyer Fund for Cancer Research to further efforts to recruit the top cancer research experts and support research for all types of cancer at the OSUCCC – James.

To date, the Buckeye Cruise for Cancer has generated more than $5.4 million for the OSUCCC – James. Cruise supporters have provided an additional $2 million in support of Ohio State’s cancer program. A critical method of fundraising onboard the cruise is the Fund a Need auction, which helps purchase important shared research equipment and technologies available for use by the OSUCCC – James’ more than 300 cancer researchers. This equipment is critical to conducting modern cancer research but is cost-prohibitive for most individual laboratories to purchase alone. Research equipment purchased with support from the Buckeye Cruise for Cancer includes a:

  • Mass Spectrometer: This instrument allows researchers to conduct pharmacokinetic studies, which show how drugs are absorbed and distributed in the body and then eliminated through natural bodily functions. Chemists and pharmacologists use the mass spectrometer to gain a better understanding of disease progression and drug resistance that will guide new cancer therapies. 
  • Ion Torrent Sequencer: This tabletop technology allows scientists to perform rapid DNA sequencing on specific patient samples and better target treatment decisions based on this genomic data and in a more cost-effective way. In the DNA sequencing could take weeks and was very expensive. This new technology allows sequencing to be done in hours and for much lower costs.
  • Flow Cytometer: This instrument enables scientists to rapidly measure the physical and chemical properties of tens of millions of cells and particles. This information helps scientists understand the basic properties of cancer, which can ultimately guide research for new treatment targets.
  • Confocal Live Cell Imaging Microscope System: This cutting-edge instrument can greatly enhance cancer researchers’ understanding of the dynamic processes involved in cancer formation, growth and metastasis by providing a high-resolution window into living cancer cells and tissues. This translates into more accurate results and better data so that we may provide the best and most effective treatments to our patients.

“We are so thankful for the support we receive through the Buckeye Cruise for Cancer and Urban and Shelley Meyer Fund – and all the fans out there in Buckeye Nation who make that support possible by participating in the cruise,” says Michael Caligiuri, MD, director of the OSUCCC and CEO of the James Cancer Hospital and Solove Research Institute. “By investing these funds into technologies that can be shared by many investigators, we are not only giving our researchers the tools they need but we are also being more efficient in our spending to maximize our resources.”

Buckeye Cruise for Cancer Registration

For more information or to register for the 2016 event, call Travel Partners Specialty Tours at 614-792-6204 or visit Space is limited and available on a first-come, first served basis.


About the OSUCCC – James

The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute strives to create a cancer-free world by integrating scientific research with excellence in education and patient-centered care, a strategy that leads to better methods of prevention, detection and treatment. Ohio State is one of only 45 National Cancer Institute-designated Comprehensive Cancer Centers and one of only four centers funded by the NCI to conduct both phase I and phase II clinical trials on novel anticancer drugs. As the cancer program’s 306-bed adult patient-care component, The James is one of the top cancer hospitals in the nation as ranked by U.S. News & World Report and has achieved Magnet designation, the highest honor an organization can receive for quality patient care and professional nursing practice. At 21 floors with more than 1.1 million square feet, The James is a transformational facility that fosters collaboration and integration of cancer research and clinical cancer care. For more information, visit

Media Contact: Amanda J. Harper
Director, Media Relations, OSUCCC – James
614-685-5420 (direct)
614-293-3737 (media main)

Contact Media Staff

Amanda Harper

Director of Media Relations

614-685-5420 (direct)

614-293-3737 (main)

Media staff are available by calling 614-293-3737 Monday through Friday between 8 a.m. and 5 p.m.


If after hours, please call 614-293-8000 (ask the operator to page the hospital administrative manager).